DISTRIBUTION AND CHARACTERIZATION OF THE [H-3] GRANISETRON-LABELED 5-HT3 RECEPTOR IN THE HUMAN FOREBRAIN

被引:55
作者
BUFTON, KE
STEWARD, LJ
BARBER, PC
BARNES, NM
机构
[1] UNIV BIRMINGHAM,SCH MED,DEPT PHARMACOL,BIRMINGHAM B15 2TT,ENGLAND
[2] UNIV BIRMINGHAM,SCH MED,DEPT PATHOL,BIRMINGHAM B15 2TT,ENGLAND
关键词
5-HT3; RECEPTOR; HUMAN PUTAMEN; H-3] GRANISETRON; VAGUS NERVE;
D O I
10.1016/0028-3908(93)90027-Z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study has demonstrated the distribution of [H-3]granisetron-labelled 5-HT3, receptors in the human forebrain with relatively high levels of this receptor in homogenates of hippocampus, caudate nucleus, putamen, nucleus accumbens and amygdala. Lower levels of 5-HT, receptors were found in other brain regions and the cervical vagus nerve. Pharmacological characterization of the labelled 5-HT3, receptor in human putamen homogenates identified a relatively low affinity for d-tubocurarine compared to the 5-HT, receptor in NG108-15 neuroblastoma-glioma cell homogenates. In contrast, the affinities of 19 other 5-HT, receptor ligands were not significantly different for the [H-3]granisetron-labelled receptor in these two preparations. Such findings indicate that the human putamen 5-HT3 recep a unique pharmacology which may have significance given the reported clinical potential of compounds active at this receptor when assessed in animal models of disease.
引用
收藏
页码:1325 / 1331
页数:7
相关论文
共 38 条
[1]   PHARMACOLOGICAL AND REGIONAL CHARACTERIZATION OF [H-3] LY278584 BINDING-SITES IN HUMAN BRAIN [J].
ABI-DARGHAM, A ;
LARUELLE, M ;
WONG, DT ;
ROBERTSON, DW ;
WEINBERGER, DR ;
KLEINMAN, JE .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :730-737
[2]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[3]   IDENTIFICATION AND CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE3 RECOGNITION SITES IN HUMAN-BRAIN TISSUE [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
IRONSIDE, JW ;
NAYLOR, RJ .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (06) :1787-1793
[4]   BEHAVIORAL PHARMACOLOGY OF 5-HT3-RECEPTOR LIGANDS [J].
BARNES, JM ;
BARNES, NM ;
COOPER, SJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) :107-113
[5]   CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT [J].
BARNES, JM ;
BARNES, NM ;
CHAMPANERIA, S ;
COSTALL, B ;
NAYLOR, RJ .
NEUROPHARMACOLOGY, 1990, 29 (11) :1037-&
[6]   IDENTIFICATION AND DISTRIBUTION OF 5-HT3 RECOGNITION SITES WITHIN THE HUMAN BRAIN-STEM [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
DEAKIN, JFW ;
IRONSIDE, JW ;
KILPATRICK, GJ ;
NAYLOR, RJ ;
RUDD, JA ;
SIMPSON, MDC ;
SLATER, P ;
TYERS, MB .
NEUROSCIENCE LETTERS, 1990, 111 (1-2) :80-86
[7]   DIFFERENTIAL BINDING CHARACTERISTICS OF AGONISTS AT 5-HT(3) RECEPTOR RECOGNITION SITES IN NG108-15 NEUROBLASTOMA-GLIOMA CELLS LABELED BY [H-3] (S)-ZACOPRIDE AND [H-3] GRANISETRON [J].
BARNES, JM ;
BARNES, NM .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2155-2158
[8]   AGONIST INTERACTIONS WITH 5-HT(3) RECEPTOR RECOGNITION SITES IN THE RAT ENTORHINAL CORTEX LABELED BY STRUCTURALLY DIVERSE RADIOLIGANDS [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
JAGGER, SM ;
NAYLOR, RJ ;
ROBERTSON, DW ;
ROE, SY .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (02) :500-504
[9]  
BARNES JM, 1991, BR J PHARM S, V102, pP252
[10]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551